Riskpilot← Back to searchSign inGet full accessNOVA SYNVÅRD AKTIEBOLAG
ABActiveOrg 5563165363Hälsovägen 20Retail sale of medical and orthopaedic goods · NACE 4774Est. 19882 employees
Revenue 2024
SEK 4,4M
-1% vs 2023
EBITDA margin
42.7%
+5% vs 2023
Equity ratio
33.4%
Financial strength
Net profit 2024
SEK 1,5M
+6% vs 2023
| Revenue | SEK 4,4M | -1% |
| EBITDA | SEK 1,9M | +5% |
| Net profit | SEK 1,5M | +6% |
| Total assets | SEK 5,2M | +36% |
| Equity | SEK 1,7M | -34% |
| Employees | 2 | — |
Legal name
NOVA SYNVÅRD AKTIEBOLAG
Org number
5563165363
Legal form
Aktiebolag
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
9 februari 1988
Share capital
SEK 150 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva verksamhet som optiker med försäljning av optiska artiklar samt bedriva förenlig verksamhet.
Address
Hälsovägen 20
Phone
+4687119147
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 134 | 3 162 | 3 770 | 4 473 | 4 446 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 397 | 832 | 1 373 | 1 811 | 1 899 |
| Depreciation & amort. | −36 | −36 | −36 | −36 | −21 |
| EBIT | 1 361 | 796 | 1 337 | 1 775 | 1 878 |
| Net financials | 1 | — | −23 | 3 | 11 |
| Profit before tax | 1 362 | 796 | 1 326 | 1 778 | 1 889 |
| Tax | −252 | −164 | −276 | −366 | −389 |
| Net profit | 1 110 | 632 | 1 050 | 1 412 | 1 500 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 449 | 1 373 | 2 659 | 3 838 | 5 208 |
| Equity | 2 788 | 1 020 | 1 230 | 2 641 | 1 741 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 661 | 353 | 1 429 | 1 197 | 3 467 |
| Total debt | 661 | 353 | 1 429 | 1 197 | 3 467 |
EBITDA margin
42.7%
This company
15.8%
Market median
+170% vs market
20202024
Equity ratio
33.4%
This company
38.2%
Market median
+13% vs market
20202024
Return on equity
86.2%
This company
18.4%
Market median
+368% vs market
20202024
Net profit margin
33.7%
This company
8.1%
Market median
+316% vs market
20202024
Asset turnover
0.85×
This company
1.12×
Market median
+24% vs market
20202024
Debt / equity
1.99×
This company
0.62×
Market median
-221% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KA | Audit | 2022 |
| Former (1) | ||
SA | Audit | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Deputy Board Member | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Sweden Property & Shares AB
NOVA SYNVÅRD AKTIEBOLAG Board members of NOVA SYNVÅRD AKTIEBOLAG also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sven Arne Richard Lindberg | Audit | 0 companies |
| Karl Anders Fornstedt | Audit | 0 companies |
| Nanie Chamoun | Board of Directors | 0 companies |
| Pierre Chamoun | Chairman | 0 companies |
| Gabriel Chamoun | Deputy Board Member | 0 companies |